CYP2D6 and dementia: A higher CYP2D6 risk score, reflecting slower drug metabolism rate, was not associated with an increase in dementia risk among amitriptyline users (HR [95% CI]: 0.90 [0.80–1.01]) or paroxetine users (HR: 0.94 [0.81–1.09]).